A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine Meeting Abstract


Authors: Shum, D.; Santos, R.; Heaney, M.; Brentjens, R.; Maslak, P.; Rosenblat, T.; Jurcic, J.; Djaballah, H.; Frattini, M. G.
Abstract Title: A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine
Meeting Title: AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy
Journal Title: Clinical Cancer Research
Volume: 21
Issue: 4 Suppl.
Meeting Dates: 2014 Jun 18-21
Meeting Location: Orlando, FL
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2015-02-15
Language: English
ACCESSION: WOS:000361385600047
DOI: 10.1158/1557-3265.pms14-b10
PROVIDER: wos
Notes: Meeting Abstract: B10 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Peter Maslak
    197 Maslak
  3. Hakim Djaballah
    101 Djaballah
  4. David Shum
    54 Shum
Related MSK Work